Pravastatin and coronary heart disease.
Bloom
J M
JM
D000319:Adrenergic beta-Antagonists / Q000191:economics / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000191:economics / Q000627:therapeutic use; D001241:Aspirin / Q000191:economics / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000517:prevention & control*; D017035:Pravastatin / Q000191:economics / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017035:Pravastatin; D001241:Aspirin